Oxygen News and Research

RSS

Stored red blood cells lose ability to release key anti-adhesive molecule

Donated red blood cells lose a key feature that diminishes their lifesaving power the longer they have been stored, according to researchers at Duke University Medical Center.

16 Jul 2011

Implantable fuel cells may obtain energy from blood sugar and oxygen

Implants that obtain their energy from blood sugar and oxygen: Dr. Sven Kerzenmacher at the Department of Microsystems Engineering (IMTEK) of the University of Freiburg is researching the development of biological fuel cells with the goal of finding an inexhaustible source of power in the human body. He has been awarded the 2011 FAM Research Prize for his dissertation by the Forum for Applied Microsystems Technology (FAM).

15 Jul 2011

Tocotrienol could help reduce stroke damage

Preventive supplementation with a natural form of vitamin E called tocotrienol could help reduce brain damage caused by strokes, researchers reported today at the 2nd International Conference on Tocotrienols and Chronic Diseases.

15 Jul 2011

Short telomeres may increase risk of emphysema

Telomeres, the body's own cellular clocks, may be a crucial factor underlying the development of emphysema, according to research from Johns Hopkins University.

15 Jul 2011

NeoStem to acquire Amorcyte

NeoStem, Inc., an international biopharmaceutical company, announced the signing of a definitive merger agreement whereby NeoStem will acquire Amorcyte, Inc., a development stage cell therapy company focusing on novel treatments for cardiovascular disease.

15 Jul 2011

Health Canada approves Vapotherm's Precision Flow Heliox device

Vapotherm, a privately held manufacturer of respiratory care devices for hospital and home use, announced today that it has received approval from the Medical Device Bureau of Health Canada for the Precision Flow Heliox device which will be launched later this year in the Canadian hospital market.

14 Jul 2011

Hop-on to launch electronic cigarette product with new FDA labels

Hop-on announced today that the Company is releasing a new starter kit for only $15.00.

13 Jul 2011

Rapid method can predict immune responses against flu vaccines

Researchers at the Emory Vaccine Center have developed a method for predicting whether someone will produce high levels of antibodies against a flu shot a few days after vaccination.

12 Jul 2011

African-Americans with glaucoma have higher oxygen levels than Caucasians

Measuring oxygen during eye surgery, investigators at Washington University School of Medicine in St. Louis have discovered a reason that may explain why African-Americans have a higher risk of glaucoma than Caucasians.

12 Jul 2011

Maternal smoking during pregnancy causes serious birth defects

To dispel any uncertainty about the serious harm caused by smoking to babies and pregnant women, the first-ever comprehensive systematic review of all studies over the past 50 years has established clearly that maternal smoking causes a range of serious birth defects including heart defects, missing/deformed limbs, clubfoot, gastrointestinal disorders, and facial disorders.

12 Jul 2011

Fibrin key to protection during gram-negative sepsis

New research from the Trudeau Institute may help to explain why anticoagulant therapies have largely failed to extend the lives of patients with sepsis. The study was led by Deyan Luo, a postdoctoral fellow in Stephen Smiley's laboratory. It shows that fibrin, a key product of the blood clotting process, is critical for host defense against Yersinia enterocolitica, a gram-negative bacterium that causes sepsis in humans and experimental mice.

11 Jul 2011

Study describes how obesity could protect against mortality in patients with RI/ARDS

Researchers have discovered that obese adults undergoing surgery are less frequently developing respiratory insufficiency (RI) and adult respiratory distress syndrome (ARDS), and that when they do, they are less likely to have fatal outcomes.

11 Jul 2011

AJMS summarizes developments related to idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a common and severe lung disease of unknown cause and with no proven therapies. But researchers are pushing forward in investigating new clues to the development and effective treatment of IPF, according to a special symposium presented in The American Journal of the Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation (SSCI).

8 Jul 2011

Smoking pregnant mums have smaller unhealthier babies

Professor Nick Macklon of Southampton University says even though most women now understand there is “overwhelming evidence” that smoking during pregnancy is harmful to the developing child, they continue to do so.

7 Jul 2011

Data fusion of three vital signs may predict serious illness in children

The research will be presented today at the Annual Scientific Meeting of the Society of Academic Primary Care, hosted this year by the Academic Unit of Primary Health Care, University of Bristol. The research was funded by the National Institute for Health Research (NIHR) School for Primary Care Research.

7 Jul 2011

First transcatheter aortic valve implantation performed at Loyola University Hospital

Toni Meyer's heart-valve disease was so severe that she suffered shortness of breath even while sitting in a chair. But after Loyola University Hospital physicians replaced her diseased aortic valve in a catheter procedure as part of a clinical trial, Meyer said she is feeling "100 percent better."

From Medtronic 7 Jul 2011

Scientists reveal that 'detox' protein could trigger pancreatic, lung cancer development

CANCER RESEARCH UK scientists have revealed that a 'detox' protein which mops up harmful 'reactive oxygen' in cells could also trigger pancreatic and lung cancer development, according to a study published in Nature, today.

7 Jul 2011

New modified adult device effective, inexpensive for children with pneumonia

Pneumonia is the leading cause of infant deaths worldwide, but pediatric researchers at the University of Alabama at Birmingham have developed an effective, inexpensive way to help breathe life into children in developing countries.

6 Jul 2011

Smart nanomaterials can disrupt blood supply to cancerous tumours

Scientists at the University of Southampton have developed smart nanomaterials, which can disrupt the blood supply to cancerous tumours.

5 Jul 2011

Beetroot juice effective for simulated competition environment

Winning margins in the Tour de France can be tight - last year just 39 seconds separated the top two riders after more than 90 hours in the saddle. When every second counts, riders do everything possible to gain a competitive advantage - from using aerodynamic carbon fibre bikes to the very latest in sports nutrition.

2 Jul 2011